Lets look at a few facts:1. Company has lost 90% value from my...

Lets look at a few facts:

1. Company has lost 90% value from my buy in price at 4c
2. Company rias will be cut 50% as all trials are done overseas and in USD
3. Science is compelling but no clear cut data presented - even the latest announcement was not deemed ASX worthy but.... has potential
4. Management is poor and take large pay and bonuses whilst our money is eroded with the share price
5. highly speculative - YES!

What would I need to see to invest:

1. Trials progressing with good data - preferably in phase 2. Markets don't seem to really care at this point on where the drugs are at in their development cycle, so I don't see a meaningful bounce in the SP.
2. Somewhat a reversal in the SP
3. Better management - I too have emailed Bec and she has not responded. Additionally, I'd like to see more skin in the game. We'll see what this raise brings
4. Potentially support via Big Pharma as seen in RAD.

Right now I'll park my money. Rather put it in RAD, PIQ or DXB. Less risky very cheap and high reward.

Please poke holes and add to this as I'd like to get a few minds on it to change my understanding. I see some really good discussions here. Thanks Heaps.